These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 11038025)

  • 1. 'Hold the Mayo': solid facts or pulp fiction?
    Punt CJ
    Ann Oncol; 2000 Aug; 11(8):919-20. PubMed ID: 11038025
    [No Abstract]   [Full Text] [Related]  

  • 2. On prejudice and facts and choices.
    Köhne CH; Folprecht G
    Ann Oncol; 2006 Feb; 17(2):185-7. PubMed ID: 16428244
    [No Abstract]   [Full Text] [Related]  

  • 3. On 5-fluorouracil therapy of colorectal cancer.
    Jensen SA
    Dan Med J; 2013 Jul; 60(7):B4603. PubMed ID: 23809976
    [No Abstract]   [Full Text] [Related]  

  • 4. The French experience with infusional 5-fluorouracil in advanced colorectal cancer.
    de Gramont A; Louvet C; Krulik M
    J Infus Chemother; 1996; 6(3):133-6. PubMed ID: 9229324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How to optimize the effect of 5-fluorouracil modulated therapy in advanced colorectal cancer.
    Ragnhammar P; Blomgren H
    Med Oncol; 1995 Sep; 12(3):187-201. PubMed ID: 8852401
    [No Abstract]   [Full Text] [Related]  

  • 6. Mature results of adjuvant colon cancer trials from the fluorouracil-only era.
    Grem JL
    J Natl Cancer Inst; 2004 May; 96(10):727-9. PubMed ID: 15150295
    [No Abstract]   [Full Text] [Related]  

  • 7. Importance of 5-fluorouracil dose-intensity in a double randomised trial on adjuvant portal and systemic chemotherapy for Dukes B2 and C colorectal cancer.
    Focan C; Bury J; Beauduin M; Herman ML; Vindevoghel A; Lecomte M; Brohée D; Canon JL; Focan-Henrard D;
    Anticancer Res; 2000; 20(6C):4665-72. PubMed ID: 11205198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Which 5-fluorouracil regimen?--the great debate.
    Vincent M; Labianca R; Harper P
    Anticancer Drugs; 1999 Apr; 10(4):337-54. PubMed ID: 10378668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Colorectal carcinoma].
    Schulthess G; Kolyvanos Naumann U; Käser L; Vetter W
    Praxis (Bern 1994); 2005 Nov; 94(44):1705-11; quiz 1712. PubMed ID: 16309014
    [No Abstract]   [Full Text] [Related]  

  • 10. [Adjuvant chemotherapy for colorectal carcinoma after curative resection].
    Murakami M; Tsukuda K; Ota T; Naito M; Shimizu N
    Nihon Rinsho; 2003 Sep; 61 Suppl 7():449-53. PubMed ID: 14574933
    [No Abstract]   [Full Text] [Related]  

  • 11. Variability in administration of 5-fluorouracil and folinic acid in standard treatment regimens for advanced colorectal cancer.
    Zalcberg JR; Harsley SR; Dooley MJ
    Intern Med J; 2002 Dec; 32(12):610-3. PubMed ID: 12512755
    [No Abstract]   [Full Text] [Related]  

  • 12. Weekly chronomodulated 48 h infusion of high-dose 5-fluorouracil modulated by methotrexate and (6S)-leucovorin in advanced colorectal cancer: a phase IB study.
    Punt CJ; Kamm YL; Wagener DJ
    Anticancer Drugs; 1997 Jun; 8(5):454-8. PubMed ID: 9215607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant therapy for resectable colorectal carcinoma with 5-fluorouracil portal vein infusion.
    Cremona F; Izzo F; Ruffolo F; Palaia R; Parisi V
    J Chemother; 1997 Apr; 9(2):140-1. PubMed ID: 9176762
    [No Abstract]   [Full Text] [Related]  

  • 14. Scheduling of fluorouracil: a forget-me-not in the jungle of doublets.
    Sobrero AF
    J Clin Oncol; 2004 Jan; 22(1):4-6. PubMed ID: 14665617
    [No Abstract]   [Full Text] [Related]  

  • 15. Biomodulation of 5-fluorouracil with antifolates.
    Bertino JR
    Semin Oncol; 1997 Oct; 24(5 Suppl 18):S18-52-S18-56. PubMed ID: 9420021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with weekly high-dose 48-hour continuous-infusion fluorouracil for advanced colorectal cancer: a Spanish Cooperative Group for Gastrointestinal Tumor Therapy (TTD) study.
    Aranda E; Díaz-Rubio E; Cervantes A; Antón-Torres A; Carrato A; Massutí T; Tabernero JM; Sastre J; Trés A; Aparicio J; López-Vega JM; Barneto I; García-Conde J
    Ann Oncol; 1998 Jul; 9(7):727-31. PubMed ID: 9739438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protracted treatment with tegafur and low dose oral leucovorin in patients with advanced colorectal carcinoma.
    Rubiales AS; del Valle ML
    Cancer; 1999 Apr; 85(8):1866-7. PubMed ID: 10223583
    [No Abstract]   [Full Text] [Related]  

  • 18. Edrecolomab alone or in combination with fluorouracil and folinic acid in the adjuvant treatment of stage III colon cancer: a randomised study.
    Punt CJ; Nagy A; Douillard JY; Figer A; Skovsgaard T; Monson J; Barone C; Fountzilas G; Riess H; Moylan E; Jones D; Dethling J; Colman J; Coward L; MacGregor S
    Lancet; 2002 Aug; 360(9334):671-7. PubMed ID: 12241873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternating bolus and continuous infusion 5-fluorouracil: a strategy to overcome resistance to this fluoropyrimidine in advanced colorectal cancer patients.
    Guglielmi A; Aschele C; Grossi F; Tixi L; Sobrero A
    Cytotechnology; 1996; 19(3):215-9. PubMed ID: 8862009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Successes in late solid tumors. New therapy offer].
    Arnheim K
    MMW Fortschr Med; 2004 Nov; 146(47):71. PubMed ID: 15624667
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.